The Minister had earlier asked the State governments to take strict action against anyone found indulged in black marketing or hoarding of Remdesivir.
The government’s decision to waive off customs duty on antiviral drug Remdesivir would help in augmenting the supply of the medicine in the wake of soaring COVID-19 cases in the country, Chemicals and Fertilizers Minister Sadananda Gowda said on Wednesday.
The government on Tuesday waived off all customs duty on imported Remdesivir injections and the drug’s active pharmaceutical ingredients (API) in order to boost supplies.
There is already a ban on the export of the Remdesivir injection from the country. “Considering the immediate requirement on the recommendation of the Department of Pharmaceuticals, the Department of Revenue has reduced customs duty on #Remdesivir and its API/KSM. This step will further augment domestic availability of Remdesivir injection,” Mr. Gowda said in a tweet.
Remdesivir Prices Cut On Government Intervention: Industry Body Remdesivir Prices Cut On Government Intervention: Industry Body Drug companies like Cadila Healthcare, Dr Reddy s Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of COVID-19.
Drug companies have reduced the price of Remdesivir injections.
New Delhi:
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government s intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
Drug companies like Cadila Healthcare, Dr Reddy s Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of COVID-19.
Coronavirus LATEST Updates: Mamata Banerjee asks Centre for 5 4-cr vaccine doses, steady supply of remdesivir msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.